Four genes responsible for recessively inherited forms of Parkinson's disease (PD) have been identified, including the recently discovered ATP13A2 (PARK9) gene. Our objective was to investigate the role of this gene in a large cohort of PD patients and controls. We extensively screened all 29 exons of the ATP13A2 coding region in 112 patients with early-onset PD (EOPD; <40 years) of mostly European ethnic origin and of 55 controls. We identified four carriers (3.6%) of novel single heterozygous ATP13A2 missense changes that were absent in controls. Interestingly, the carrier of one of these variants also harbored two mutations in the Parkin gene. None of the carriers had atypical features previously described in patients with two mutated...
Objective: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations amo...
textabstractMutations in the ATP13A2 (PARK9) and FBXO7 (PARK15) genes are linked to different forms ...
Together with point mutations, homozygous deletions or duplications in PARK2 are responsible for the...
Parkinson’s disease (PD) is a major neurodegenerative disorder for which the etiology and pathogenes...
A family history of Parkinson’s disease (PD) is the most commonly reported risk factor after age, su...
OBJECTIVES: To assess the association of ATP13A2 gene mutation among patients with early onset Parki...
Both recessive and dominant genetic forms of Parkinson's disease have been described. The aim of thi...
OBJECTIVE: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations amo...
Objective: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations amo...
OBJECTIVE: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations amo...
A multiethnic series of patients with early-onset Parkinson's disease (EOP) was studied to assess th...
IntroductionBoth recessive and dominant genetic forms of Parkinson's disease have been described. Th...
Objective: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations am...
IntroductionGenetic mutations associated with early-onset Parkinson's disease (EOPD) vary widely amo...
We analysed the parkin gene in a large consecutive series (146) of unrelated early onset Parkinson's...
Objective: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations amo...
textabstractMutations in the ATP13A2 (PARK9) and FBXO7 (PARK15) genes are linked to different forms ...
Together with point mutations, homozygous deletions or duplications in PARK2 are responsible for the...
Parkinson’s disease (PD) is a major neurodegenerative disorder for which the etiology and pathogenes...
A family history of Parkinson’s disease (PD) is the most commonly reported risk factor after age, su...
OBJECTIVES: To assess the association of ATP13A2 gene mutation among patients with early onset Parki...
Both recessive and dominant genetic forms of Parkinson's disease have been described. The aim of thi...
OBJECTIVE: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations amo...
Objective: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations amo...
OBJECTIVE: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations amo...
A multiethnic series of patients with early-onset Parkinson's disease (EOP) was studied to assess th...
IntroductionBoth recessive and dominant genetic forms of Parkinson's disease have been described. Th...
Objective: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations am...
IntroductionGenetic mutations associated with early-onset Parkinson's disease (EOPD) vary widely amo...
We analysed the parkin gene in a large consecutive series (146) of unrelated early onset Parkinson's...
Objective: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations amo...
textabstractMutations in the ATP13A2 (PARK9) and FBXO7 (PARK15) genes are linked to different forms ...
Together with point mutations, homozygous deletions or duplications in PARK2 are responsible for the...